Search

Your search keyword '"Capobianchi M.R."' showing total 123 results

Search Constraints

Start Over You searched for: Author "Capobianchi M.R." Remove constraint Author: "Capobianchi M.R."
123 results on '"Capobianchi M.R."'

Search Results

101. Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study

102. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

103. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021

104. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

105. Evaluation of HIV transmission clusters among natives and foreigners living in Italy

106. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

107. Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort

108. A novel next generation sequencing assay as an alternative to currently available methods for hepatitis C virus genotyping

109. Evaluation of an automated extraction system in combination with Affigene® CMV Trender for CMV DNA quantitative determination: Comparison with nested PCR and pp65 antigen test

110. Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

111. Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL

112. Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort

113. Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014

114. Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy

115. First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison

116. Phylogenetic Analysis of West Nile Virus Isolates, Italy, 2008–2009

117. Multicenter comparative study of Epstein–Barr virus DNA quantification for virological monitoring in transplanted patients

118. Absence of Neuroinvasive Disease in a Liver Transplant Recipient Who Acquired West Nile Virus (WNV) Infection from the Organ Donor and Who Received WNV Antibodies Prophylactically

119. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study

120. Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort

121. Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy

122. Multicenter quality control study for human cytomegalovirus DNAemia quantification

123. Retrospective screening of solid organ donors in Italy, 2009, reveals unpredicted circulation of West Nile virus

Catalog

Books, media, physical & digital resources